Description
Vefend 200 mg is a broad-spectrum antifungal medication containing Voriconazole USP, formulated as a film-coated tablet. It is indicated for the treatment of various serious fungal infections, including:
Invasive Aspergillosis
-
Candidemia
-
Esophageal Candidiasis
-
Fluconazole-resistant serious invasive Candida infections (including Candida krusei)
-
Serious fungal infections caused by Scedosporium spp. and Fusarium spp.
Manufactured by The ACME Laboratories Ltd., Vefend is available in 50 mg and 200 mg tablet strengths. The recommended dosage varies based on patient age, weight, and the severity of the infection. For adults weighing over 40 kg, the typical regimen starts with 400 mg twice daily on the first day, followed by 200 mg twice daily for 7–14 days. Dosage adjustments may be necessary based on clinical response and tolerability.
Note: Vefend should be administered under the guidance of a healthcare professional, with monitoring for potential side effects and drug interactions
.webp)
.jpeg)
.webp)
.jpeg)
.jpeg)
.png)
.png)
.png)
.webp)
Change Language